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CASE REPORT
INTRODUCTION
AIDS (acquired immunodeficiency syndrome) was
first reported in the United States in 1981 and has since
become a major worldwide epidemic. AIDS is caused
by HIV (human immunodeficiency virus). By killing or
damaging cells of the body’s immune system, HIV
 progressively destroys the body’s ability to fight
infections and certain cancers. People diagnosed with
AIDS may get life-threatening diseases called
opportunistic infections, which are caused by
commensally microbes such as viruses or bacteria that
usually do not make healthy people sick.1
More than 900,000 cases of AIDS have been
reported in the United States since 1981. As many as
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ABSTRACT
The incidence of AIDS/HIV infection has been increasing worldwide. Patients with AIDS/HIV
 infection is at high risk to get opportunistic infection which is often become life-threatening. Common
infections associated with AIDS/HIV are tuberculosis (TB) infection and viral hepatitis. Commensal
organism found in human body is actually not pathogenic. Blastocystis hominis is generally considered
as commensal organism of intestinal tract and might cause opportunistic infection in patients with AIDS.
We reported a case of young male patient with AIDS/HIV infection and evidence of opportunistic
infection of Blastocystis hominis found in ascitic fluid along with concomitant lung TB and viral hepatitis.
Patient was well-responded to treatment of B. Hominis.
Keywords: AIDS/HIV infection, opportunistic infection, Blastocystis hominis
950,000 Americans may be infected with HIV,
one-quarter of who are unaware of their infection.
The epidemic is growing most rapidly among minority
 populations and is a leading killer of African-
American males ages 25 to 44. According to the
Centers for Disease Control and Prevention (CDC),
AIDS affects nearly seven times more African
Americans and three times more Hispanics than whites.
In recent years, an increasing number of African-
American women and children are being affected by
HIV/AIDS. In 2003, two-thirds of U.S. AIDS cases
in both women and children were among African-
Americans.1
CDC’s definition of AIDS includes all HIV-infected
people who have less than 200 CD4+ T cells per cubic
millimeter of blood (healthy adults usually have CD4+
T-cell counts of 1,000 or more). In addition, the
definition includes 26 clinical conditions that affect
people with advanced HIV disease. Most of these
conditions are opportunistic infections. In people with
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AIDS, these infections are often severe and
sometimes fatal because the immune system is so rav-
aged by HIV that the body cannot fight off certain
bacteria, viruses, fungi, parasites, and other microbes.1,2
One of  the opportunistic infection is an infection of
Blastocystis hominis.1-3
The taxonomic classification of Blastocystis
hominis is mired in controversy. It has been previously
considered as yeasts, fungi, or amoeboid, flagellated,
or sporozoan protozoa. Recently, however, based on
molecular studies, especially dealing with the sequence
information on the complete SSUrRNA gene,
B. hominis has been placed within an informal group,
the stramenopiles.4 Stramenopiles are defined, based
on molecular phylogenies, as a heterogeneous
evolutionary assemblage of unicellular and multi-
cellular protists including brown algae, diatoms,
chrysophytes, water molds, slime nets, etc.11 
B. hominis has been recognized as a common
 inhabitant of the human intestinal tract for many years,
although its taxonomic position remains uncertain.
Recent evidences, however, indicates that B. hominis
is potentially pathogenic, a) if it is found in stool in
remarkable quantity, i.e. five or more cell per x 40
microscopic field, b) the absence of other pathogenic
organisms in the sample and c) response to treatment
with iodoquinol or metronidazole. The presence or
the absence of clinical symptoms depends on
the interaction between the host and parasite. Although
it is less clear, commensally organisms may become
pathogenic opportunistically.3,5-6
B. hominis has three morphological forms
(vacuolar, granular and amoeboid), but recent studies
have revealed several additional forms; cyst, avacuolar,
and multivacuolar. The mode of transmission is
uncertain, but probably with fecal-oral route.
The disease is characterized by acute or chronic and
recurrent diarrhea, sometimes self-limited,
accompanied by abdominal pain, tenesmus, anorexia,
nausea and/or vomiting, cramps, fatigue and fever.
In immunosuppressed patients, the outcome is
generally severe.5
The prevalence of B. hominis has been found to
be similar in asymptomatic and symptomatic patients
by Udkow and Markell.9,13 Its prevalence varies from
place to place and according to the studied population.
The prevalence of B. hominis in healthy persons was
reported between 0.5% and 20.3%. On the other hand,
its prevalence was detected as 43% in homosexual
persons and between 25% and 46% in AIDS patients.
Its prevalence, in Turkey varies from 1.15% to 13.16%
in healthy persons but there is no information about the
immunocompromised persons. The prevalence of
B. hominis (7.7%) was found to be similar to that
reported in healthy persons. Even though
the prevalence (10.9%) was highest in the samples
obtained from patients with malignancy, it was not
different from that reported in healthy persons.3,8-9
CASE ILLUSTRATION
Mr J 29 years old, single, lived in Jakarta, came to
hospital with chief complaint in abdominal pain since
two weeks before admission. Since two months
before admission the patient felt abdominal pain and
discomfort in his stomach. He often felt nausea and
vomiting, lost of appetite, decreased of body weight,
diarrhea and mild fever. Since two weeks before
admission his abdominal pain worsened, his abdomen
was very painful. The pain was localized. The patient
had constipation but he could flatus. Urination was
normal.
Beside those problems, he also had cough with
white sputum without blood streak. There was no
history of shortness of breath or night sweat. When
the patient came to the hospital, he was on treatment
of tuberculosis for 8 months from public medical
services (primary health care). Before that the patient
came to other hospital, under went chest X-ray and
was given anti TB drug for one month but he stopped
the medication by himself because he felt better.
He under went a test for HIV in hospital and the result
was positive.
There was no history of illness, no history of family
illness. He was an intravenous drug abuser for 10 years.
He used needle together with his friends. He also used
marijuana and other illegal drugs. He was jobless.
He had been smoking for 15 years, minimum 1 pack
a day. He was a last son of 4 children in the family.
A physical examination, patient looked seriously ill,
fully alert. Blood pressure was about 100/70 mmHg,
heart pulse about 100 x/minute, respiratory rate about
28x/minute and temperature about 37.8oC. Body
weight 165 cm and body height 50 kg. The conjunctiva
of the eye was pale, sclera was icteric. Ears, nose and
throat was normal. Jugular vein pressure was 5-2 cm
H2O. There was oral thrush. Lymph node was
palpable in left neck (½ cm x ½ cm x 1 cm). On chest
examination, it was symmetrical on static and dynamic
condition; breath sound was sonor, vesicular, there was
rales in all hemisphere, no wheezing. Heart sound was
normal, regular, there was no murmur and no gallop.
Abdomen was not really distended, turgor was good,
and there was a lamp in left upper region. The lamp
size was 5 x 4 x 3 cm with unclear border and
tenderness and undulation positive. Chessboard
phenomenon was not found. Liver and spleen size was
difficult to be evaluated because the patient felt very
painful. Shifting dullness was found. The bowel sound
was decreased.
Laboratory examination found microcytic
Volume 8, Number 2, August  2007 59
Diagnosis and Management of Blastocystis Hominis Infection in Patient with HIV/AIDs
hypochromic anemia (hemoglobin level was 8.5/dl with
MCV 76.9 fl, MCH 22 pg, and MCHC 25.1 g/dL).
Leukocyte count was in normal range (leukocyte count
8,200/mm3), but there was thrombocytopenia
(thrombocyte count 128.000/mm3). There was increase
in erythrocyte sedimentation rate (ESR 110 mm).
Ureum, creatinin and electrolytes were normal.
Transaminase enzyme was increased (AST 82 U/l ALT
27 U/l). Urinalysis was normal. The albumin level was
1.9 g/dl and the globulin level was normal (6.1 g/dL).
And the total bilirubin level was 10.3 mg/dl with
increased direct bilirubin 7.8 mg/dl. Chest X-ray showed
infiltrate in apex and basal, and there was pleural
effusion. ECG was unremarkable.
The problems at admission were abdominal pain
due to suspected intra abdominal mass with
differential diagnosis peritoneal abscess or partial
obstruction with impending perforation and
tuberculosis (TB) peritonitis. The other problems are
pulmonary TB with secondary infection, bisitopenia,
HIV reactive, oral candidiasis, liver function disorder
and hypoalbuminemia. It was planned to perform is
feces analysis, ascites fluid analysis, USG abdomen,
acid fast bacilli, gram, MOR, liver function test,
seromarker for viral hepatitis, echocardiography, throat
swap, diff count, ELISA, CD4, viral load and
consultation to surgery department and psychiatry
department. The patient was given O2 2 liter/minute,
IVFD of dextrose and normal saline, sistenol 500 mg
three times daily, ceftriaxone 2 g once daily,
intravenous metronidazole 500 mg three times daily,
rifampisin 450 mg once daily, INH 300 mg once daily,
and pirazinamid 500 mg twice daily and
supplementation of vitamin B6 10 mg, mycostatine
3 x 1 cc drop, and packed red cell transfusion until
the hemoglobin level more than 10 g/dL.
Abdominal pain due to suspected intra abdominal
mass with differential diagnosis peritoneal abscess or
partial obstruction with impending perforation and
tuberculosis peritonitis based on abdominal pain in whish
the abdomen was not really distended, turgor was good,
and there was a lump in left upper region. The size of
the lump was 5 x 4 x 3 cm with unclear border,
tenderness and undulation positive. Chessboard
phenomenon was not found. Liver and spleen
enlargement could not be evaluated because
the patient felt very painful. Shifting dullness was found.
The bowel sound was decrease.
Pulmonary tuberculosis with secondary infection
based on chronic cough with sputum, fever, body
weight loss, night sweat, history of tuberculosis
treatment, moist rales in the lungs, palpable lymph nodes
and no leukocytosis. Chest X-ray showed specific
process.
Bisitopenia based on fatigue, lost of appetite,
diarrhea, no bloody stool, tachypneu, tachycardia.
Laboratory examination showed microcytic
hypochrome anemia and thrombocytopenia. Microcytic
hypochrome anemia was suspected due to iron
deficiency with differential diagnosis anemia chronic
disease and anemia of chronic bleeding.
The patient was HIV positive based on test
the laboratory finding from UKI hospital. The patient
was a drug abuser. He used needle together with his
friends. He also used marijuana and other illegal drug.
Oral candidiasis based on history of intravenous drug
abuser for 10 years, oral thrush positive. Oral
candidiasis was suggested due to HIV infection.
Liver function disorder based on elevated
transaminase serum, thrombocytopenia, and hypo-
albuminemia. This condition was suggested due to
viral hepatitis B and C infection with differential
diagnosis drug induced hepatitis. Hypoalbuminemia
based on lost of appetite, diarrhea, and low level of
albumin. Hypoalbuminemia was suggested due to
malnutrition with differential diagnosis of
malabsorption and liver function disorder.
In the next day, the patient condition worsened. His
abdominal pain worsens, and the patient wanted to
discharge. Digestive surgery department suspected
an impending perforation with intra abdominal mass
and suspected partial obstruction with differential
diagnosis was suspected tuberculosis. The patient was
consult to the department of psychiatry and
the diagnosis from department of psychiatry was
psychotic because of physical condition and withdrawal
syndrome was very possible. It was planned to
perform three position of abdominal X-ray.
The patient was given nasogastric tube to decompress,
but the tube was always pulled by the patient.
The patient was not cooperative and really difficult to
handle.
The result of USG showed hepatosplenomegali and
ascites with a lot of fibrin. CD4 result was 67,
seromarker of hepatitis C and HbsAg were positive.
Patient and the family refused to do anything related
to the surgery include three position of abdominal
X-ray, but the patient was given hepatoprotector and
cotrimoxasole.
In the 16th day after admission, the ascites fluid was
taken with USG guidance. In USG there was a lot of
fibrin. The clinical pathology analysis was failed
because the fluid could not be analyzed. Analysis of
parasitology from ascites fluid stated there were full
of Blastocystis hominis, and the patient was suggested
to receive intravenous Metronidazole 750 three times
daily and ciprofloxacine 500 mg twice daily.
The patient escaped from hospital, but he came back
to admission. The condition in his second admission
was worse than the previous one. In the 20th day of
hospitalization, the patient died due to sepsis.
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DISCUSSION
This case is presented due to the increasing
 incidence of HIV infection. The incidence of
B hominis would be increased is concordance with
the increasing of HIV case. Beside that the patient
has other opportunistic infection like lung TB and oral
candidosis. This case can be a good sample of HIV
case with the infection of commensal microorganism
in human body. The case is more interesting because
B. hominis was found in ascites fluid.
The patient was intravenous drug abuser for more
than 10 years. He used needle together with his friends.
Some of his friend was death because of HIV/AIDS.
He also used marijuana and other illegal drugs. His
HIV test was reactive with CD4 only 67.
In the journal, during the course of HIV infection, most
people experience a gradual decline in the number of
CD4+ T cells, although some may have abrupt and
dramatic drops in their CD4+ T-cell counts. A person
with CD4+ T cells above 200 may experience some of
the early symptoms of HIV disease. Others may have
no symptoms even though their CD4+ T-cell count is
below 200.1,2 Lymph node of the patient was palpable
in left neck (½ cm x ½ cm x 1 cm). As the immune
system worsens, a variety of complications start to take
over. For many people, the first signs of infection are
large lymph nodes or “swollen glands” that may be
Figure 2. USG showed ascites, hepatomegaly and a lot of fibrin
enlarged for more than 3 months. Other symptoms
often experienced months to years before the onset of
AIDS include lack of energy, weight loss, frequent
fevers and sweats, persistent or frequent yeast
 infections (oral or vaginal), persistent skin rashes or
flaky skin, pelvic inflammatory disease in women that
does not respond to treatment, short-term memory loss.
Some people develop frequent and severe Herpes
 infections that cause mouth, genital, or anal sores, or
a painful nerve disease called shingles.1
The patient was jobless. Many people are so
debilitated by the symptoms of AIDS that they cannot
hold a steady job nor do household chores. Other people
with AIDS may experience phases of intense
life-threatening illness followed by phases in which they
function normally.1
The patient may, however, have a flu-like illness
within a month or two after exposure to the virus. This
illness may include fever, headache, tiredness enlarged
lymph nodes (glands of the immune system easily felt
in the neck and groin) these symptoms usually
disappear within a week to a month and are often
mistaken for those of another viral infection. During
this period, people are very infectious, and HIV is
present in large quantities in genital fluids. More
persistent or severe symptoms may not appear for 10
years or more after HIV first enters the body in adults,
or within 2 years in children born with HIV infection.
This period of “asymptomatic” infection varies greatly
in each individual. Some people may begin to have
symptoms within a few months, while others may be
symptom-free for more than 10 years.1
Even during the asymptomatic period, the virus is
actively multiplying, infecting, and killing cells of the
immune system. The virus can also hide within infected
cells and lay dormant. The most devastating effect of
HIV infection is a decline in the number of CD4
positive T (CD4+) cells found in the blood-the immune
system’s key infection fighters. The virus slowly
disables or destroys these cells without causing
symptoms.1
Since two months before admission the patient felt
abdominal pain and discomfort in his stomach. He
often felt nausea and vomiting, lost of appetite, decrease
of body weight, diarrhea and mild fever. Since two
weeks before admission his abdominal pain worsen,
his abdomen was very painful, with no spread of pain.
The patient has no defecation but he could flatus.
Urination was normal. Symptoms of opportunistic
infections common in people with AIDS include
coughing and shortness of breath, seizures and lack of
coordination, difficult or painful swallowing, mental
symptoms such as confusion and forgetfulness, severe
and persistent diarrhea, fever, vision loss, nausea,
abdominal cramps, and vomiting, weight loss and
Figure 3. Full of Blastocystis hominis in the ascites fluid
Figure 1. Patient condition with asymmetrical abdomen and his
chest X-ray
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extreme fatigue, severe headaches, coma. One of the
opportunistic infection is caused by Blastocystis
hominis.2,4-6
Whether Blastocystis hominis can cause
symptomatic infection in humans is a point of active
debate. This is because of the common occurrence of
the organism in both asymptomatic and symptomatic
persons. Those who presume symptoms could be
related to infection with this parasite have described
a spectrum of illness including watery diarrhea,
abdominal pain, perianal pruritus, and excessive
flatulence.5,7-9
Diagnosis is based on finding the cyst-like stage in
feces. Permanently stained smears are preferred over
wet mount preparations because fecal debris may be
mistaken for the organisms in the latter.  Do not wash
specimens in water (e.g. during concentration
procedures) as this will lyses the organisms, resulting
in false negatives.7-9 In abdominal USG there was a lot
of fibrin. The clinical pathology analysis was failed
because the fluid was lyses. Analysis of parasitology
from ascites fluid stated there were full of Blastocystis
hominis, and the patient was suggested to receive
intravenous metronidazole 750 mg three times and
ciprofloxacine 500 mg twice daily. The next step should
be analysis of the feces, but the patient and the family
was not really cooperative at the time and the patient
discharged without doctor’s permission from hospital.
When we would check it the patient became worse
and finally he died before we analyzed his feces. How
B. hominis could be found in ascitic fluid might be due
to perforation of the gut.
Blastocystosis is caused by Blastocystis hominis,
a parasite that commonly resides in the caecum and
large bowel of human beings. The pathogenicity of
B hominis has been an issue of controversy. Initially, it
was known as commensal organism of intestinal tract,
however, recent information from retrospective
studies and experimental models in animals support its
pathogenicity. Blastocystosis has been characterized
by symptoms including diarrhea, abdominal pain,
nausea, vomiting, flatulence, anorexia, and malaise and
has been implicated in patients diagnosed with irritable
bowel syndrome. Data on treatment of blastocystosis
are limited primarily to anecdotal studies in which
metronidazole and iodoquinol, the most commonly
recommended therapies, were used showing variable
results.2 A recent, single-blind, placebo-controlled study
of metronidazole administered 1.5 g/day for
10 consecutive days showed improvement of diarrhea
in the metronidazole-treated group and a higher rate of
parasite clearance.13-15 The patient was given
intravenous metronidazole 500 mg three times daily and
ciprofloxacin 500 mg twice daily but it only last for
2 days because the patient was died. In the literature
the most recommended quinolone is iodoquinolone but
in Indonesia it is very difficult to find the regimen.
In recent journal said that Nitazoxanide is indicated
in the United States for treatment of persistent
diarrhea caused by Giardia and Cryptosporidium and
is being investigated for treatment of diarrhea caused
by enteroviruses, Clostridium difficile-associated
diarrhea, and Crohn’s disease. It is active against
a broad range of enteropathogens including protozoa,
bacteria, and viruses by 3 mechanisms: interference
with energy metabolism in anaerobic organisms
(protozoa and bacteria), inhibition of transcription/
replication in infected cells (viruses), and inhibition of
secretion of proinflammatory cytokines. Double-blind,
placebo-controlled clinical studies have shown that
a 3-day course of nitazoxanide is effective in treating
diarrhea and enteritis caused by Cryptosporidium
species, Giardia intestinalis, and Entamoeba
histolytica, and in eliminating the organisms from
the stool. The same course of treatment also has been
reported to be effective in treating enteric infections
caused by B. hominis, Balantidium coli, and
Cyclospora cayetanensis.15
The patient has symptom of abdominal pain and
chronic diarrhea. From USG we found a lot of fibrin.
In physical examination there was no chest board
phenomenon. He also has lung TB. The differential
diagnosis of the abdominal pain was peritonitis TB.
The analysis of the ascitic fluid was failed because
the fluid was lyses.
 When the patient comes to the hospital, he has been
in tuberculosis medication for 8 months from public
medical service (primary health care). Before that
the patient has come to private hospital, did chest
X-ray and was given tuberculosis drugs for 1 month
but he stopped the medication by himself because
he was getting better. Lymph node was palpable in left
neck (½ cm x ½ cm x 1 cm). On chest examination,
it was symmetrical on static and dynamic condition;
it was sonor, vesicular, there was rales in all hemisphere,
no wheezing. The patient was given rifampisin 450 mg
once daily, INH 300 mg once daily and pirazinamid
500 mg twice daily and supplementation of
vitamin B6.16-20
It is necessary to treat patient with lung TB in HIV
consider that mortality rate is higher than lung TB in
HIV patient. Therapy for lung TB improvement TB
symptoms but also in markers of HIV disease as
CD count rise and viral loads fall independent of
specific therapy for HIV. Principally the treatment not
quietly different. But there are special consideration
include the potential for drug interaction when
antituberculosis therapy and antiretroviral co
administered,  timing for initiation of HIV related therapy
for person diagnosed with both infections
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simultaneously, the potential for prolongation of therapy
in persons with advanced immunosupression due to
HIV infection. Not adjustment in dosage of anti
tuberculosis medication for HIV-infected person.
Although the poor absorption of anti tuberculosis drugs
in HIV-infected person has been theoretical concern,
poor absorption leading to failure has been rarely
reported and not to be clinically significant.1-2
Patient with HIV/AIDS and TB infection at
the same time is recommended to start treatment for
TB promptly. For patient who has diagnosis of TB and
HIV simultaneously, treatment for TB must be
initiated but the decision about when to start
antiretroviral therapy is still controversial. Most of
the centers suggest the administration of Anti Retroviral
(ARV) after two-month treatment of TB after initial
phase.2,17-20 The patient has not given ARV yet
because the transaminase enzyme was elevated due
to viral hepatitis B and C infection.
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